Alzheimer’s Disease Fast Facts | CNN
CNN — Here is a look at Alzheimer’s disease, a progressive brain disorder that leads to loss of memory and...
clinical trials
FDA decision on experimental Alzheimer’s drug expected this week | CNN
CNN — The US Food and Drug Administration could decide this week whether to grant accelerated approval to the experimental...
Pandemic fueled alcohol abuse, especially among women, but there are treatment options | CNN
Editor’s Note: In the final two episodes of “This Is Life With Lisa Ling,” the series explores alcoholism in America...
Pain relief from marijuana comes from a belief it helps, study finds | CNN
CNN — Some people suffering pain from cancer and other chronic diseases turn to marijuana to ease their suffering, but...
HIV vaccine candidate induces immune response in early clinical trial: ‘An important step forward’ | CNN
CNN — An experimental HIV vaccine has been found to induce broadly neutralizing antibodies among a small group of volunteers...
Experimental drug appears to slow progression of Alzheimer’s disease in clinical trial but raises safety concerns | CNN
CNN — The experimental drug lecanemab shows “potential” as an Alzheimer’s disease treatment, according to new Phase 3 trial results,...
Experimental therapy gantenerumab fails to slow or improve Alzheimer’s memory loss in clinical trials | CNN
CNN — An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer’s or those...
By the next RSV season, the US may have its first vaccine | CNN
CNN — It’s shaping up to be a severe season for respiratory syncytial virus infections – one of the worst...
After promising data, experts say many questions remain over an experimental Alzheimer’s drug | CNN
CNN — The experimental Alzheimer’s drug lecanemab made big news last week when the companies testing it released trial results...
Alzheimer’s drug slows progression of cognitive decline in clinical trial, drugmakers say | CNN
CNN — A monoclonal antibody treatment for Alzheimer’s disease called lecanemab slows the progression of cognitive decline by 27% compared...
